466 related articles for article (PubMed ID: 33940597)
21. Low-dose aspirin does not lower in vivo platelet activation in healthy smokers.
Pernerstorfer T; Stohlawetz P; Stummvoll G; Kapiotis S; Szekeres T; Eichler HG; Jilma B
Br J Haematol; 1998 Sep; 102(5):1229-31. PubMed ID: 9753050
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Qian W; Tao L; Wang Y; Zhang F; Li M; Huang S; Wang A; Chen W; Yue Z; Chen L; Liu Y; Huang C; Zhang L; Li Y; Lu Y
J Vasc Res; 2015; 52(3):197-209. PubMed ID: 26488158
[TBL] [Abstract][Full Text] [Related]
23. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
Santilli F; Lapenna D; La Barba S; Davì G
Free Radic Biol Med; 2015 Mar; 80():101-10. PubMed ID: 25530150
[TBL] [Abstract][Full Text] [Related]
25. Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.
Lippi G; Franchini M; Targher G
Thromb Haemost; 2007 Jun; 97(6):1059-60. PubMed ID: 17549315
[No Abstract] [Full Text] [Related]
26. Platelet-targeted pharmacologic treatments as anti-cancer therapy.
Gresele P; Momi S; Malvestiti M; Sebastiano M
Cancer Metastasis Rev; 2017 Jun; 36(2):331-355. PubMed ID: 28707198
[TBL] [Abstract][Full Text] [Related]
27. The Platelet Lifeline to Cancer: Challenges and Opportunities.
Haemmerle M; Stone RL; Menter DG; Afshar-Kharghan V; Sood AK
Cancer Cell; 2018 Jun; 33(6):965-983. PubMed ID: 29657130
[TBL] [Abstract][Full Text] [Related]
28. Use of antiplatelet agents in sepsis: a glimpse into the future.
Akinosoglou K; Alexopoulos D
Thromb Res; 2014 Feb; 133(2):131-8. PubMed ID: 24103487
[TBL] [Abstract][Full Text] [Related]
29. Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.
Serebruany VL; Midei MG; Meilman H; Malinin AI; Lowry DR
Int J Clin Pract; 2006 Jul; 60(7):863-6. PubMed ID: 16846403
[TBL] [Abstract][Full Text] [Related]
30. The influence of citrate concentrations on PFA-100 closure times, platelet hyper-reactivity and aspirin monitoring.
Harrison P
Thromb Res; 2010 Aug; 126(2):e137-8. PubMed ID: 19931889
[No Abstract] [Full Text] [Related]
31. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.
Natarajan A; Zaman AG; Marshall SM
Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103
[TBL] [Abstract][Full Text] [Related]
32. Role of platelets in inflammation and cancer: novel therapeutic strategies.
Dovizio M; Alberti S; Guillem-Llobat P; Patrignani P
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):118-27. PubMed ID: 24118902
[TBL] [Abstract][Full Text] [Related]
33. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.
Dai H; Chen J; Tao Q; Zhu J; Zhang F; Zheng L; Qiu Y
Postgrad Med J; 2003 Sep; 79(935):522-6. PubMed ID: 13679549
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study.
Mikami J; Kurokawa Y; Takahashi T; Miyazaki Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Gastric Cancer; 2016 Jul; 19(3):817-26. PubMed ID: 26486505
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the interactions between metastatic human breast cancer cells and platelets by β-nitrostyrene derivatives.
Wei CK; Chang FR; Hsieh PW; Wu CC
Life Sci; 2015 Dec; 143():147-55. PubMed ID: 26546721
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of platelet activation in acute coronary syndromes.
Stakos DA; Tziakas DN; Stellos K
Curr Vasc Pharmacol; 2012 Sep; 10(5):578-88. PubMed ID: 22338573
[TBL] [Abstract][Full Text] [Related]
37. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
[TBL] [Abstract][Full Text] [Related]
38. Platelet Apoptotic Response May Be Associated With the Capacity of Aspirin to Inhibit Platelets.
Zamorano-León JJ; Gascón M; Martínez CH; Freixer G; Guerra R; Zekri-Nechar K; Bernardo E; Serna-Soto M; Segura A; Giner M; García-Fernández MA; Macaya C; López-Farré AJ
J Cardiovasc Pharmacol; 2020 Nov; 76(5):584-591. PubMed ID: 33170592
[TBL] [Abstract][Full Text] [Related]
39. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
Tobin WO; Kinsella JA; Coughlan T; Collins DR; O'Neill D; Murphy RP; Egan B; Tierney S; Feeley TM; McCabe DJ
Eur J Neurol; 2013 Feb; 20(2):344-52. PubMed ID: 22994699
[TBL] [Abstract][Full Text] [Related]
40. Response to antiplatelet therapy is independent of endogenous thrombin generation potential.
Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C
Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
